Mastectomy scars following breast reconstruction: Should routine histologic analysis be performed?

Plastic and Reconstructive Surgery

Volumn 123, Issue 4, 2009, Pages 1141-1147

  Warner, Robert M ^a   Wallace, David L ^a   Ferran, Nicholas A ^a   Erel, Ertan ^a   Park, Alan J ^a   Prinsloo, Daniel J ^a   Waters, Ruth ^a  

^a SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CARCINOMA; BREAST RECONSTRUCTION; CARCINOMA IN SITU; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; RECURRENT CANCER; SCAR;

ADULT; AGED; BREAST NEOPLASMS; CICATRIX; FEMALE; HUMANS; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 67849098859     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31819f25d5     Document Type: Article

References (25)

1. Royal College of Pathologists. Histopathology and cytopathology of limited or no clinical value. Available at: http://www.rcpath.org/publications. Accessed October 10, 2008.
2. Soldin MG, Grob M, Dawson A, Cooper MA. Routine histological examination of the mastectomy scar at the time of breast reconstruction: Important oncological surveillance? Br J Plast Surg. 2004;57:143-145.
3. Zambacos GJ, Wilson PA, Miminas D, Morris RJ. Routine histological examination of the mastectomy scar at the time of breast reconstruction. Br J Plast Surg. 2005;58:122.
4. Mathen V, Khan S, O'Brien M, Jones L, Harries S, Clarke D. Routine histological examination of the mastectomy scar at the time of breast reconstruction. J Plast Reconstr Aesthet Surg. 2006;59:1248-1249.
5. Alam M, Kiely C, Shah SH, Lawlor C, O'Donnell M. Mastectomy scar histopathology of limited clinical value. Ann Plast Surg. 2006;57:374-375.
6. Woerdeman LA, Kortmann JB, Hage JJ. Routine histologic examination of 728 mastectomy scars: Did it benefit our patients? Plast Reconstr Surg. 2006;118:1288-1292.
7. Clemons M, Danson S, Hamilton T, Goss P. Locoregionally recurrent breast cancer: Incidence, risk factors and survival. Cancer Treat Rev. 2001;27:67-82.
8. Fisher B, Anderson S, Bryant J. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
9. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143-1150.
10. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: The National Cancer Institute Randomized Trial. Cancer2003;98: 697-702.
11. Jatoi I, Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: A pooled analysis of updated results. Am J Clin Oncol. 2005;28: 289-294.
12. Nahabedian MY. Routine histologic examination of 728 mastectomy scars: Did it benefit our patients? Plast Reconstr Surg. 2007;120:353.
13. Sinha M, Gupta S, Hogg FJ. A case for sending mastectomy scars for routine histopathology. Plast Reconstr Surg. 2007; 120:1085-1086.
14. National Institute for Health and Clinical Excellence. Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer. Available at: http://www.nice.org.uk/nicemedia/pdf/TA112Niceguidance.pdf. Accessed October 10, 2008.
15. Rea D. Guidelines for the use of Adjuvant Aromatase Inhibitors in Early Breast Cancer. Available at: http://www.birminghamcancer.nhs.uk/viewdoc.ashx?id= mSFzwWDbOb% 2blXiqmRnm1og%3d%3d. Pan-Birmingham Cancer Network. Accessed October 10, 2008.
16. National Institute for Health and Clinical Excellence. Improving outcomes in breast cancer: Manual update, 2002. Available at: http://www.nice.org.uk/ guidance/index.jsp? action=download&o=28763. Accessed October 10, 2008.
17. Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol. 2005;31(Suppl 1):1-21.
18. Clemons M, Hamilton T, Goss P. Does treatment at the time of locoregional failure of breast cancer alter prognosis? Cancer Treat Rev. 2001;27:83-97.
19. Engel J, Eckel R Aydemir U, et al. Determinants and prognoses of locoregional and distant progression in breast cancer. IntJ Radiat Oncol Biol Phys. 2003;55:1186-1195.
20. Voogd AC, van Oost FJ, Rutgers EJ, et al. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 2005;41:2637-2644.
21. Buchanan CL, Dorn PL, FeyJ, etal. Locoregional recurrence after mastectomy: Incidence and outcomes. J Am Coll Surg. 2006;203:469-474.
22. Langstein HN, Cheng MH, Singletary SE, et al. Breast cancer recurrence after immediate reconstruction: Patterns and significance. Plast Reconstr Surg. 2003;111:712-720.
23. Montgomery DA, Krupa K, Jack WJ, et al. Changing pattern of the detection of locoregional relapse in breast cancer: The Edinburgh experience. Br J Cancer 2007;96: 1802-1807.
24. Cheng SH, Horng CF, West M, et al. Genomic prediction of locoregional recurrence after mastectomy in breast cancer. J Clin Oncol. 2006;24:4594-4602.
25. Sanghani M, Balk E, Cady B, Wazer D. Predicting the risk of local recurrence in patients with breast cancer: An approach to a new computer-based predictive tool. Am J Clin Oncol. 2007;30:473-480.